查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞培養市場 - COVID-19 的增長、趨勢、影響、預測 (2023-2028)
市場調查報告書
商品編碼
1190253

細胞培養市場 - COVID-19 的增長、趨勢、影響、預測 (2023-2028)

Cell Culture Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內 (2022-2027)，細胞培養市場預計將以 11.0% 的複合年增長率增長。

隨著 COVID-19 的爆發，世界各地的許多生物技術公司、製藥公司、政府機構和研究機構開始專注於開發有效的疫苗和新型治療藥物以克服這一局面。 細胞培養可以作為開髮用於治療 COVID-19 的新型疫苗的潛在平台。 此外，市場參與者在這個方向上採取的舉措也對市場的增長產生了重大影響。 例如，2021 年 1 月，Captivate Bio 推出了一系列細胞培養工具，以幫助抗擊美國的 COVID-19 和其他新興疾病。 因此，COVID-19 對市場增長產生了顯著影響。

對個性化醫療的需求不斷增長，對疫苗、生物製藥和人造器官的需求不斷增長，再加上技術進步和產品/消耗品的推出等關鍵因素將推動預測期內的市場增長。正在推動

根據 GLOBOCAN 統計數據，2020 年全球估計有 1930 萬新癌症病例，預計到 2040 年將達到 3020 萬。 癌症的這種增長創造了對精準醫療的需求，並且隨著細胞培養在個性化醫療的發展中發揮關鍵作用，預計未來幾年對細胞培養的需求將會增加。 此外，藥物和生物製藥的積極研發也對市場增長做出了重大貢獻。 例如，根據歐洲製藥商協會聯合會2022年的報告，歐洲製藥業已支出396.56億歐元的研發費用，預計2022年將達到415億歐元。 這種對研發的日益關注創造了對細胞培養物來測試藥物功效的需求，並正在推動市場的增長。

產品發布預計也將促進市場增長。 例如，2021 年 3 月，賽默飛世爾科技推出了一款新產品“Gibco 類人血漿培養基 (HPLM)”。 它是首批模擬人體血漿代謝曲線的細胞培養基之一，旨在為研究人員提供人體細胞生長的真實畫面。

此外，技術先進和創新產品的推出也推動了市場的增長。 例如，2022 年 2 月，Nucleus Biologics 推出了 Krakatoa。 它是市場上第一家創新的培養基製造商之一，可幫助研究人員在使用時製造細胞培養基。

因此，由於上述因素，預計細胞培養市場在預測期內將呈現大幅增長。 然而，與細胞培養研究相關的高成本和新興國家缺乏細胞培養研究的基礎設施可能會阻礙市場增長。

主要市場趨勢

預計藥物開發部門在預測期內將快速增長。

細胞培養是醫學研究和藥物發現不可或缺的一部分。 藥物開發是一個耗時且成本高昂的過程，需要經過多個階段才能完成，從靶點識別到先導化合物的發現和優化、臨床前驗證、臨床試驗和臨床使用批准。 基於細胞的高通量篩選 (HTS) 目前對在組織培養優化的塑料表面上以二維 (2D) 方式生長的培養細胞進行。 隨著 3D 細胞培養的出現，HTS 過程變得更加簡單和精確。

此外，政府對藥物發現的支持也有助於這一細分市場的增長。 例如，2020 年 7 月，印度聯邦政府發起了藥物發現黑客馬拉松“Nishank”。 此次黑客馬拉松是全國首次支持藥物發現過程，不僅得到了市場參與者的支持，也得到了各部委的支持。

此外，預計市場進入者的舉措也將促進該細分市場的增長。 例如，2021 年 11 月，默克與 GI Innovation 簽署了諒解備忘錄 (MoU)，以促進韓國的生物醫學發展。 根據諒解備忘錄，默克將提供包括 CHOZN 平台、細胞培養基和下游工藝開發在內的技術和服務，以加速研發重要的挽救生命的癌症和過敏相關藥物。 這些舉措也有助於該部門的增長。

因此，由於上述因素，預計市場在預測期內將出現顯著增長。

北美將在預測期內主導全球細胞培養市場

北美目前在細胞培養市場佔據主導地位，預計在預測期內也將遵循同樣的趨勢。 這主要是由於對個性化醫療的需求不斷增長，加上對疫苗、生物製藥和人造器官的需求不斷增加，以及市場上主要參與者的存在。

根據美國癌症協會2022年的統計數據，預計2022年美國將有1,918,030例癌症新發病例。 癌症等疾病負擔的增加催生了對精準醫療的需求，導致對細胞培養產品及其開發耗材的需求增加，推動了市場增長。

市場進入者推出的產品預計也將促進市場增長。 例如，2020 年 12 月，eNuvio Canada 推出了首批完全可重複使用的 3D 細胞培養微孔板之一，即 EB-Plate。 預計此類發布將推動該地區的市場增長。 此外，2022 年 2 月，KromaTiD 推出了一套全面的細胞和血培養生長、分離、處理和質量控制服務。 公司推出此類產品和服務預計將推動市場增長，因為這也將增加對細胞培養產品和耗材的需求。

因此，由於上述因素，預計北美地區的細胞培養市場在預測期內將出現顯著增長。

競爭格局

細胞培養市場競爭適中，由幾家大型企業組成。 從市場份額的角度來看，目前幾家大型企業佔據了市場主導地位。 Thermo Fisher Scientific、Danaher Corporation、Sartorius AG、Merck KGaA 等主要市場參與者的存在也加劇了整個市場競爭對手之間的競爭。 此外，主要參與者的產品改進和細胞培養平台改進也加劇了競爭。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 對疫苗、生物製藥和人造器官的需求不斷增長
    • 對個性化醫療越來越感興趣
  • 市場製約因素
    • 與基於細胞的研究相關的高成本
    • 新興國家/地區缺乏基於細胞的研究基礎設施
  • 行業吸引力 - 波特五力分析
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品和消耗品
    • 按產品分類
      • 生物安全設備
      • 離心機
      • 低溫儲存設備
      • 培養系統/生物反應器
      • 孵化器
      • 管道設備
      • 其他
    • 消耗品
      • 中等
      • 血清
      • 試劑
  • 通過申請
    • 生物製藥
    • 藥物開發
    • 基因治療
    • 組織培養與工程
    • 疫苗製造
    • 其他用途
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Biospherix
    • Hi-Media Laboratories
    • Merck KGaA
    • Promocell GmbH
    • Sartorius AG
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Sekisui XenoTech LLC
    • Lonza Group
    • Agilent Technologies Inc.
    • Becton, Dickinson and Company
    • Cytiva
    • Corning Incorporated

第7章 市場機會今後動向

簡介目錄
Product Code: 67166

The cell culture market is expected to witness a CAGR of 11.0% over the forecast period (2022-2027).

With the onset of COVID-19, many biotech and pharmaceutical firms, government organizations in various countries, and research institutes started to focus on the development of effective vaccines and new therapeutics to overcome the situation. Cell culture may serve as a potential platform for the development of novel vaccines for the treatment of COVID-19. Additionally, initiatives taken by the market players in such directions also led to a significant impact on the market's growth. For instance, in January 2021, Captivate Bio launched its portfolio of cell culture tools to assist in the fight against COVID-19 and other emerging diseases in United States. Thus, COVID-19 had a pronounced impact on the growth of the market.

The major factors such as the growing demand for personalized medicine coupled with the rise in the demand for vaccines, biopharmaceuticals, and artificial organs coupled with the advancement in technology and the launch of products and consumables are driving the growth of the market over the forecast period.

According to GLOBOCAN Statistics, there were an estimated 19.3 million new cases of cancer around the world in the year 2020, and it is projected to reach 30.2 million by 2040. Such an increasing burden of cancer creates the need for precision medicine, so the demand for cell culture is expected to increase over the coming years as cell culture plays a vital role in the development of personalized medicine. Additionally, increasing research and development in pharmaceuticals and biopharmaceuticals also contributes largely to the growth of the market. For instance, according to the European Federation of Pharmaceutical Industries and Associations, 2022 report, the pharmaceutical industry in Europe incurred expenses of EUR 39,656 million for its research and development, and for 2022, this expense is expected to be EUR 41,500 million. Such an increasing focus on research and development creates the need for cell cultures for testing the effectiveness of the drug and thus drives the growth of the market.

The launch of products is also expected to drive the growth of the market. For instance, in March 2021, Thermo Fisher Scientific launched its new Gibco Human Plasma-like Medium (HPLM). It is one of the first types of cell culture medium that mimics the metabolic profile of human plasma and is designed to provide researchers with a realistic view of cell growth within the human body. ​

Additionally, the launch of technologically advanced and innovative products also propels the growth of the market. For instance, in February 2022, Nucleus Biologics launched Krakatoa. It is an innovative, one of the first to market media makers that helps researchers to manufacture cell culture media at the point of use.

Thus, owing to the abovementioned factors, the cell culture market is expected to show considerable growth over the forecast period. However, the high cost associated with cell-based research and the lack of infrastructure for cell-based research in emerging economies may impede the growth of the market.

Key Market Trends

Drug Development Segment is Expected to Witness Rapid Growth Over the Forecast Period.

Cell culture is an integral part of medical research and drug discovery. Drug development is a time-consuming and costly procedure that is completed in multiple stages, from target identification to lead discovery and optimization, preclinical validation, and clinical trials, culminating in approval for clinical use. Cell-based high throughput screening (HTS) is currently being carried out on cultured cells propagated in two dimensions (2D) on plastic surfaces optimized for tissue culture. With the emergence of 3D cell culture, the process of HTS has become easier and more accurate.

Furthermore, the support from the governments of different countries for drug discovery is also contributing to the growth of the segment. For instance, in July 2020, the Union Government of India launched the Drug Discovery Hackathon "Nishank". This Hackathon is a first-of-its-kind national initiative for supporting the drug discovery process and is supported by various departments as well as market players.

Additionally, the initiatives taken by the market players are also expected to boost the growth of the market segment. For instance, in November 2021, Merck signed a Memorandum of Understanding (MoU) with GI Innovation, to facilitate biomedicine development in Korea. As per the MoU, Merck provides technologies and services, including the CHOZN platform, cell culture media, and downstream process development, to promote research and development of critical life-saving cancer treatments, as well as drugs for allergy-related conditions. Such initiatives also contribute to the growth of the segment.

Thus, owing to the abovementioned factors, the market segment is expected to project significant growth over the forecast period.

North America Dominates the Global Cell Culture Market Over the Forecast Period

North America is currently dominating the cell culture market and is expected to follow the same trend over the forecast period. This is majorly attributed to the growing demand for personalized medicine coupled with the rise in the demand for vaccines, biopharmaceuticals, and artificial organs, and the presence of key players in the market.

According to the American Cancer Society's 2022 statistics, there will be an estimated 1,918,030 new cases of cancer in United States in 2022. Such an increasing burden of diseases such as cancer creates the need for precision medicine, which leads to the increase in demand for cell culture products and consumables for their development and hence drives the growth of the market.

The launch of products by the market players is also expected to drive the growth of the market. For instance, in December 2020, eNuvio Canada launched one of the first completely reusable 3D cell culture microplates, namely the EB-Plate. Such launches are expected to propel the growth of the market in the region. Additionally, in February 2022, KromaTiD launched a comprehensive suite of cell and blood culture growth, isolation, processing, and quality control services. The launch of such products and services by the companies also boosts the demand for cell culture products and consumables and is thus expected to drive the growth of the market.

Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show considerable growth over the forecast period.

Competitive Landscape

The cell culture market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA, and others, also increases the overall competitive rivalry of the market. Additionally, the product advancements and improvements in cell culture platforms by the major players are also increasing the competition.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in the Demand for Vaccines, Biopharmaceuticals and Artificial Organs
    • 4.2.2 Growing Focus on Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with Cell Based Research
    • 4.3.2 Lack of Infrastructure for Cell-based Research in Emerging Economies
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product and Consumables
    • 5.1.1 Product
      • 5.1.1.1 Biosafety Equipment
      • 5.1.1.2 Centrifuges
      • 5.1.1.3 Cryostorage Equipment
      • 5.1.1.4 Culture Systems/Bioreactors
      • 5.1.1.5 Incubators
      • 5.1.1.6 Pipetting Instruments
      • 5.1.1.7 Others
    • 5.1.2 Consumables
      • 5.1.2.1 Media
      • 5.1.2.2 Sera
      • 5.1.2.3 Reagents
  • 5.2 By Application
    • 5.2.1 Biopharmaceuticals
    • 5.2.2 Drug Development
    • 5.2.3 Gene Therapy
    • 5.2.4 Tissue Culture and Engineering
    • 5.2.5 Vaccine Production
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biospherix
    • 6.1.2 Hi-Media Laboratories
    • 6.1.3 Merck KGaA
    • 6.1.4 Promocell GmbH
    • 6.1.5 Sartorius AG
    • 6.1.6 Thermo Fisher Scientific
    • 6.1.7 Danaher Corporation
    • 6.1.8 Sekisui XenoTech LLC
    • 6.1.9 Lonza Group
    • 6.1.10 Agilent Technologies Inc.
    • 6.1.11 Becton, Dickinson and Company
    • 6.1.12 Cytiva
    • 6.1.13 Corning Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS